{"name":"Absci Corporation","slug":"absci","ticker":"ABSI","exchange":"NASDAQ","domain":"absci.com","description":"Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.","hq":"Vancouver, WA","founded":0,"employees":"140","ceo":"Sean McClain","sector":"AI Drug Discovery","stockPrice":5.57,"stockChange":0.27,"stockChangePercent":5.09,"marketCap":"$868M","metrics":{"revenue":1836000,"revenueGrowth":-81.8,"grossMargin":0,"rdSpend":0,"netIncome":-118436000,"cash":125705000,"dividendYield":0,"peRatio":-8.3,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"AB-101 patent cliff ($100M at risk)","drug":"AB-101","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Absci Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Absci Corporation reported its financial results for the fourth quarter and full year 2023, highlighting revenue growth and progress in its AI-driven drug discovery pipeline.","drugName":"","sentiment":"positive"},{"date":"2023-11-15","type":"deal","headline":"Absci Enters into Collaboration Agreement with Pfizer to Develop Novel Therapies","summary":"Absci Corporation announced a collaboration agreement with Pfizer to develop novel therapeutics using Absci's AI-driven drug discovery platform.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE1MaDdyalJfcmRQc0c3M2lQay16cUtXZ0pPSFQzX240dm84X3RERy1vRHdGRDJfQjJOVzQ3UllreF8xX2wwQUtMRTcybWtMc2FYRXNLZmd2T2Y1TnpScVF5emdfMDNHNnpyNVZn0gFrQVVfeXFMTUxoN3JqUl9yZFBzRzczaVBrLXpxS1dnSk9IVDNfbjR2bzhfdERHLW9Ed0ZEMl9CMk5XNDdSWWt4XzFfbDBBS0xFNzJta0xzYVhFc0tmZ3ZPZjVOelJxUXl6Z18wM0c2enI1Vmc?oc=5","date":"2026-03-13","type":"earnings","source":"AlphaStreet","summary":"What to Expect When Absci Reports Q4 Results March 247 Amid AI Drug Discovery Momentum - AlphaStreet","headline":"What to Expect When Absci Reports Q4 Results March 247 Amid AI Drug Discovery Momentum","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOM1ZTVGNFOTlwSWF5TjlFWUhxa1ZhZmJSU1MtUVg2aDktX3JWbXpUMlU4YTdPeGRra2w0US1EbVhER3lzeDVrT3hBTmszNGlfUnlpbUlxV2xlVUtFd2pmM0FNVHNpRTN1dWJmY2Vpc2tpdkxKY21lbHBvVEM1Ri1zazl6M1BBMVczbmxjZ240YUd4dWZUYUNlWWdWQ01UU3VTaFVoMXJyOEF6clQtS2c?oc=5","date":"2026-03-03","type":"pipeline","source":"Investing.com","summary":"Absci names Ransi Somaratne as chief medical officer - Investing.com","headline":"Absci names Ransi Somaratne as chief medical officer","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-06","type":"pipeline","source":"simplywall.st","summary":"Insiders Who Purchased US$582.6k Of Absci Stock May Not Have Expected 17% Tumble - simplywall.st","headline":"Insiders Who Purchased US$582.6k Of Absci Stock May Not Have Expected 17% Tumble","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxONnB0SWotMFVENGhWb2tZSzNuQ0VvekRsR0x4bXpCOTlCUkdhNmk5ZnQ2cWhLWVp5cHNnR3pMb0tfUTVUMUVvQ2RRUXVxckh6TmlGSks1TWVGY09ha2s2Y3puM2tfUU1VV3dOaUVBclhUdjhLbkExQ3JhR2k5cTZseTZrYXc5N1F3RXllRTE0V3NaUXdReENLUEs1TzdHUQ?oc=5","date":"2026-02-03","type":"pipeline","source":"Seeking Alpha","summary":"OpenAI considers backing AI-led drug discovery firms: report - Seeking Alpha","headline":"OpenAI considers backing AI-led drug discovery firms: report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQaWRsNHB1VzU2MmluYUZSZWpwS3hSUHBjU1N1cVF5azdZRHZ4YlZQZGtXNHZTY1h6RDVLTkc1N09fZlFLY2xlMzY1clR3ZERSc0lIaFduRGdyTGFkUmEtdWI2dEVUUHFONWc0VFRFM09Da2tyWnlSWTI0VDRIRzdWQXFLNGtTU3JwamFlR01fRFMtTERybFhkN3FFQzZZcFU?oc=5","date":"2025-10-13","type":"pipeline","source":"MarketBeat","summary":"2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk - MarketBeat","headline":"2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNZU1CdlUtVU11RFNYWl9PNTVqNDRMamtFdVFyLTRYbWxHOTFEQ1F2TlBLQmx0VmNiZlNqWFRvR1UwUzhudFZoNnlvQUVKTm1JMER4aDJjM2xJVUZnQWRTTmNLNzFoN2cxOVA1bnZsNDhuQU81UVBFRlExQmhSdm1pWWctNEtlN3JFWDFBc1VreGcxWXpVLU9kS2hTeXA3MmZfTXV5dXYtWlFVNEdZeFpSLWoyeTVtSnQ2YzBNRTIwNUYwQ2p2VlFEalJKUGpyTzlwVFZFMHZVOXoyaEpaVEE?oc=5","date":"2025-10-08","type":"pipeline","source":"Benzinga","summary":"Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday - Benzinga","headline":"Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQSHY1M3lTSDBSSmczNGoyN08wWjY2UXhyNTVnVzI1dVBLd0QtcnFqU1FuUXlnWDdjNjZoa2J4SGpaOEJwc2RvSWFCOWFxVTFnTFRJVU9lZEVkNFBhN08yLVEtbjkxQU5ISUR3eWllNnBFeXlqTEJaQXdQM1I0Z1MwM3pZcVEwZWM?oc=5","date":"2025-09-21","type":"pipeline","source":"Yahoo Finance","summary":"Absci Corporation (ABSI) Secures $64M Financing to Drive AI Drug Discovery Through 2028 - Yahoo Finance","headline":"Absci Corporation (ABSI) Secures $64M Financing to Drive AI Drug Discovery Through 2028","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxONzJhN1RYazJaa2w5cHJ4T1pKU21lZmtUNlpZTV9YckEzcjFPMXZRZUhwZjVaV1JlcVhFWkpUZmZPS2hITWxteU83QjgyRkpkTUE1Zi10b3dfTWxFdFNzaUZlUHJrdy1RXzdNNEVZeUZNbnNaOUVGYnQyd05aWHhPSDd4WlBZVXh1N291Rks1ajdoWjU0MFh2TE0xUmE0bFJFNC1rS0xRWjNvT1JycFRJ?oc=5","date":"2025-09-17","type":"pipeline","source":"Seeking Alpha","summary":"Absci Corporation: ABS-101 Has Both First-Gen And Next-Gen Competitors - Seeking Alpha","headline":"Absci Corporation: ABS-101 Has Both First-Gen And Next-Gen Competitors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQX3VNcEdjMnJCQjAyRHlRUHFTc19wYjc1dmJHdExZMTB5S2R0QnExUkhiRXExMFJJQUcydF9iZUJVT2t1bUtva3p0RGhudkNOZW1TUUl5ODhhcWtyUnBxbElXSlM0N1dLUkZmUEZlVy12dmxhaHVqdDFVcWhKV3Z6OGNRdkRzOVd3LUNuNDZxU3dpWXZ5SWc?oc=5","date":"2025-08-29","type":"pipeline","source":"Seeking Alpha","summary":"Absci: Still A Work In Progress, Fighting To Survive - Seeking Alpha","headline":"Absci: Still A Work In Progress, Fighting To Survive","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-05-23","type":"pipeline","source":"simplywall.st","summary":"Absci Corporation's (NASDAQ:ABSI) recent 10% pullback adds to one-year year losses, institutional owners may take drastic measures - simplywall.st","headline":"Absci Corporation's (NASDAQ:ABSI) recent 10% pullback adds to one-year year losses, institutional owners may take drasti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9rQWdnbXdQNHNYV1BrNS0yc19yaWZnZWZIelFEalpZVFR1ODc3MW53bV80UThxMDRnVHhjY0dkb3VzME84RjJrSUhLWTU2cmVycnBj?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"ABSI Stock Price, News & Analysis - Stock Titan","headline":"ABSI Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOUy0zbkhBcFppS29yR0lvN0VjSVkxTE5wWnZWV1ZRNmMyVWk0Y3d2dGpOVERQeWZvSWlxbTJ4bmZLOGljS1FWelpTZlMtNHpXOFhOYlE4RXlKNHZaM2RZU0l0aWFORXN0SWx6dmZaQWNYYmpqWWhhX016eTF4MWs1TDdRem9ZT3M?oc=5","date":"2025-01-22","type":"deal","source":"Yahoo Finance","summary":"Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside - Yahoo Finance","headline":"Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside","sentiment":"neutral"}],"patents":[{"drugName":"AB-101","drugSlug":"generic","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":100000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Vertex Pharmaceuticals","Biogen","Pfizer"],"therapeuticFocus":["Oncology","Rare Genetic Disorders"],"financials":{"source":"yahoo_finance","revenue":2800000,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":2800000},{"period":"2024-12-31","value":4534000},{"period":"2023-12-31","value":5718000},{"period":"2022-12-31","value":5747000}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":81418000,"rdSpendHistory":[{"period":"2025-12-31","value":81418000},{"period":"2024-12-31","value":63859000},{"period":"2023-12-31","value":48067000},{"period":"2022-12-31","value":58908000}],"sgaSpend":35058000,"operatingIncome":-125418000,"operatingIncomeHistory":[{"period":"2025-12-31","value":-125418000},{"period":"2024-12-31","value":-108888000},{"period":"2023-12-31","value":-94180000},{"period":"2022-12-31","value":-106750000}],"netIncome":-115183000,"netIncomeHistory":[{"period":"2025-12-31","value":-115183000},{"period":"2024-12-31","value":-103106000},{"period":"2023-12-31","value":-110566000},{"period":"2022-12-31","value":-104904000}],"eps":-0.84,"epsHistory":[{"period":"2025-12-31","value":-0.84},{"period":"2024-12-31","value":-0.94},{"period":"2023-12-31","value":-1.2},{"period":"2022-12-31","value":-1.15}],"cash":20025000,"cashHistory":[{"period":"2025-12-31","value":20025000},{"period":"2024-12-31","value":41213000},{"period":"2023-12-31","value":72362000},{"period":"2022-12-31","value":59955000}],"totalAssets":216297000,"totalLiabilities":26848000,"totalDebt":5302000,"equity":189449000,"operatingCashflow":-92925000,"operatingCashflowHistory":[{"period":"2025-12-31","value":-92925000},{"period":"2024-12-31","value":-72402000},{"period":"2023-12-31","value":-64636000},{"period":"2022-12-31","value":-81339000}],"capex":-1107000,"capexHistory":[{"period":"2025-12-31","value":-1107000},{"period":"2024-12-31","value":-404000},{"period":"2023-12-31","value":-860000},{"period":"2022-12-31","value":-16175000}],"freeCashflow":-94032000,"dividendsPaid":null,"buybacks":null,"employees":140,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":8617000,"ebit":-29695000,"ebitda":-26867000,"period":"2025-12-31","revenue":650000,"epsBasic":-0.2,"netIncome":-29562000,"rdExpense":25347000,"epsDiluted":-0.2,"grossProfit":null,"operatingIncome":-36142000},{"sga":8441000,"ebit":-28557000,"ebitda":-25715000,"period":"2025-09-30","revenue":378000,"epsBasic":-0.2,"netIncome":-28706000,"rdExpense":19249000,"epsDiluted":-0.2,"grossProfit":null,"operatingIncome":-30154000},{"sga":8528000,"ebit":-30382000,"ebitda":-27382000,"period":"2025-06-30","revenue":593000,"epsBasic":-0.24,"netIncome":-30569000,"rdExpense":20458000,"epsDiluted":-0.24,"grossProfit":null,"operatingIncome":-31393000},{"sga":9472000,"ebit":-26271000,"ebitda":-23199000,"period":"2025-03-31","revenue":1179000,"epsBasic":-0.21,"netIncome":-26346000,"rdExpense":16364000,"epsDiluted":-0.21,"grossProfit":null,"operatingIncome":-27729000},{"sga":8828000,"ebit":-28853000,"ebitda":-25619000,"period":"2024-12-31","revenue":665000,"epsBasic":-0.25,"netIncome":-28983000,"rdExpense":18377000,"epsDiluted":-0.25,"grossProfit":null,"operatingIncome":-29774000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":5.57,"previousClose":5.3,"fiftyTwoWeekHigh":6.72,"fiftyTwoWeekLow":2.24,"fiftyTwoWeekRange":"2.24 - 6.72","fiftyDayAverage":3.61,"twoHundredDayAverage":3.29,"beta":2.38,"enterpriseValue":705006784,"forwardPE":-8.3,"priceToBook":5.03,"priceToSales":472.56,"enterpriseToRevenue":383.99,"enterpriseToEbitda":-6.05,"pegRatio":0,"ebitda":-116437000,"ebitdaMargin":0,"freeCashflow":-41475376,"operatingCashflow":-97393000,"totalDebt":4415000,"debtToEquity":2.6,"currentRatio":6.59,"returnOnAssets":-37.3,"returnOnEquity":-63.9,"analystRating":"1.4 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":8,"targetMeanPrice":8.53,"targetHighPrice":12,"targetLowPrice":4.2,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":13,"institutionHeldPercent":70,"sharesOutstanding":155905056,"floatShares":146136045,"sharesShort":33709177,"shortRatio":7.26,"shortPercentOfFloat":21.6,"epsTrailing":-0.82,"epsForward":-0.67,"revenuePerShare":0.01,"bookValue":1.11,"officers":[{"age":35,"name":"Mr. Sean  McClain","title":"Founder, CEO, President & Director"},{"age":52,"name":"Dr. Zachariah  Jonasson Ph.D.","title":"Chief Business Officer & CFO"},{"age":null,"name":"Mr. Todd  Bedrick CPA","title":"Senior VP & Chief Accounting Officer"},{"age":null,"name":"Mr. Alexander  Khan CPA","title":"CVP of Finance & Head of Investor Relations"},{"age":50,"name":"Ms. Shelby  Walker J.D.","title":"Chief Legal Officer"},{"age":null,"name":"Ms. Jeanne  Schreuder M.B.A., SPHR","title":"Senior Vice President of People & Experience"},{"age":null,"name":"Mr. Wen  Sha","title":"Chief of Staff"},{"age":null,"name":"Dr. Christine  Lemke D.V.M., M.B.A., Ph.D.","title":"Senior Vice President of Portfolio & Growth Strategy"}],"industry":"Biotechnology","irWebsite":"","website":"https://www.absci.com","phone":"360 949 1041"}}